Filing Flows › Comparisons › FBIO vs ARCT
Fortress Biotech vs Arcturus Therapeutics Holdings: FBIO and ARCT compared
Fortress Biotech is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $18.3M for Arcturus Therapeutics Holdings (Q3 2026). Fortress Biotech is growing faster (+14% against +7% a year earlier). Arcturus Therapeutics Holdings is more profitable, with an operating margin of -50.2% against -53.5%.
Where the money goes: FBIO and ARCT
Fortress Biotech (FBIO) · Q2 2026
Fortress Biotech, Q2 2026: revenue $18.7M (+14% year over year), operating margin -53.5%, net earnings $602K, operating cash flow −$59.3M. The chart follows the revenue to costs, profit and cash.
Arcturus Therapeutics Holdings (ARCT) · Q3 2026
Arcturus Therapeutics Holdings, Q3 2026: revenue $18.3M (+7% year over year), operating margin -50.2%, net loss $7.4M, operating cash flow −$6.9M. The chart follows the revenue to costs, profit and cash.
| Fortress Biotech (FBIO) | Arcturus Therapeutics Holdings (ARCT) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $18.7M | $18.3M |
| Revenue growth, Y/Y | +14% | +7% |
| Operating margin | -53.5% | -50.2% |
| Net earnings | $602K | −$7.4M |
| Net margin | 3.2% | -40.5% |
| Operating cash flow | −$59.3M | −$6.9M |
Where the revenue comes from
Fortress Biotech
- Journey: $18.5M (99%)
- Fortress: $208K (1%)
Arcturus Therapeutics Holdings
- Collaboration Revenue: $16.9M (92%)
- Grant: $1.4M (8%)
Questions
Which is bigger, Fortress Biotech or Arcturus Therapeutics Holdings?
Fortress Biotech is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $18.3M for Arcturus Therapeutics Holdings (Q3 2026).
Is Fortress Biotech or Arcturus Therapeutics Holdings growing faster?
Fortress Biotech is growing faster (+14% against +7% a year earlier).
Which is more profitable, Fortress Biotech or Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings is more profitable, with an operating margin of -50.2% against -53.5%.
More: Fortress Biotech earnings · how Fortress Biotech makes money · Arcturus Therapeutics Holdings earnings · how Arcturus Therapeutics Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.